ATRA vs C · rev $128.9M vs P/E 16, rev $85.22B
Atara Biotherapeutics Inc (ATRA) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
ATRA currently screens at market cap $87.1M. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the ATRA and C stock pages for the full models.
Not investment advice.